Emcure Pharmaceuticals Ltd (EMCURE) — Net Asset Quality Index
Emcure Pharmaceuticals Ltd (EMCURE) has a Net Asset Quality Index of 51.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs96.12 Billion minus total liabilities of Rs46.36 Billion yields net assets of Rs49.77 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of Emcure Pharmaceuticals Ltd to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Emcure Pharmaceuticals Ltd Net Asset Quality Index Over Time (2022–2026)
This chart shows how Emcure Pharmaceuticals Ltd's Net Asset Quality Index has evolved across 5 annual periods from 2022 to 2026. As of March 2026, the index stands at 51.8%, representing net assets of Rs49.77 Billion against total assets of Rs96.12 Billion INR. See how liquid is Emcure Pharmaceuticals Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Emcure Pharmaceuticals Ltd (2022–2026)
The table below presents the year-by-year Net Asset Quality Index for Emcure Pharmaceuticals Ltd from 2022 to 2026, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see EMCURE stock market capitalisation.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 51.8% | Rs49.77 Billion | Rs96.12 Billion | Rs46.36 Billion | ▼ -4.6 pp |
| 2025 | 56.4% | Rs46.42 Billion | Rs82.33 Billion | Rs35.91 Billion | ▲ +16.4 pp |
| 2024 | 40.0% | Rs31.22 Billion | Rs78.06 Billion | Rs46.84 Billion | ▲ +0.3 pp |
| 2023 | 39.7% | Rs26.50 Billion | Rs66.73 Billion | Rs40.23 Billion | ▲ +4.8 pp |
| 2022 | 34.9% | Rs21.14 Billion | Rs60.63 Billion | Rs39.49 Billion | — |